These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24389893)

  • 1. Comparison of MRI features for the differentiation of hepatic angiomyolipoma from fat-containing hepatocellular carcinoma.
    Wang SY; Kuai XP; Meng XX; Jia NY; Dong H
    Abdom Imaging; 2014 Apr; 39(2):323-33. PubMed ID: 24389893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of triple-phase CT findings for the differentiation of fat-deficient hepatic angiomyolipoma from hepatocellular carcinoma in non-cirrhotic liver.
    Jeon TY; Kim SH; Lim HK; Lee WJ
    Eur J Radiol; 2010 Mar; 73(3):601-6. PubMed ID: 19200676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison.
    Cai PQ; Wu YP; Xie CM; Zhang WD; Han R; Wu PH
    Abdom Imaging; 2013 Jun; 38(3):482-9. PubMed ID: 22996326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Histopathological Features and CT/MRI Imaging Performances in Hepatic Angiomyolipoma Patients.
    Ding H; Wei H; Liu H; Chen Y; Xue X; Weng H
    Ann Hepatol; 2017; 16(5):759-764. PubMed ID: 28809731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Angiomyolipoma Versus Hepatocellular Carcinoma in the Noncirrhotic Liver on Gadoxetic Acid-Enhanced MRI: A Diagnostic Challenge.
    Lee SJ; Kim SY; Kim KW; Kim JH; Kim HJ; Lee MG; Yu ES
    AJR Am J Roentgenol; 2016 Sep; 207(3):562-70. PubMed ID: 27248975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ADC measurement in differential diagnosis of focal hepatic lesions.
    Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E
    Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
    Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
    AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiomyolipoma of the liver: analysis of typical features and pitfalls based on own experience and literature.
    Anysz-Grodzicka A; Pacho R; Grodzicki M; Koperski L; Górnicka B; Cieszanowski A; Zieniewicz K; Krawczyk M
    Clin Imaging; 2013; 37(2):320-6. PubMed ID: 23465986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Mizuno N; Kawada H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
    Park MJ; Kim YK; Park HJ; Hwang J; Lee WJ
    J Comput Assist Tomogr; 2013; 37(6):872-81. PubMed ID: 24270108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced sonographic appearances of two primary hepatic epithelioid angiomyolipomas.
    Chai V; Fox A; Chong L; House E; Sutherland T
    J Clin Ultrasound; 2020 Jun; 48(5):283-286. PubMed ID: 32012287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelioid angiomyolipoma of the liver: cross-sectional imaging findings of 10 immunohistochemically-verified cases.
    Xu PJ; Shan Y; Yan FH; Ji Y; Ding Y; Zhou ML
    World J Gastroenterol; 2009 Sep; 15(36):4576-81. PubMed ID: 19777618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.